• Info
  • Insider Ownership

Insider Trading & Ownership of Ronald C. Renaud Jr.

Location
Cambridge, MA
Summary
The estimated net worth of Ronald C. Renaud Jr. is at least $12,254 dollars as of 12 Jun 2025. Ronald C. Renaud Jr. is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $12.3K.
Signature
/s/ Allison Ambrose, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Ronald C. Renaud Jr. and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Ronald C. Renaud Jr. has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $12,254.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Atara Biotherapeutics, Inc. ($12,254).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Ronald C. Renaud Jr.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ATRA Atara Biotherapeutics, Inc. Director $12,254 23 Jun 2022
CERE Cerevel Therapeutics Holdings, Inc. President & CEO, Director $0 01 Aug 2024
IMA Ikena Oncology, Inc. Director 09 Jun 2022
TBIO Translate Bio, Inc. Chief Executive Officer, Director 14 Sep 2021
UPB Upstream Bio, Inc. Director 10 Jun 2025

Insider Transactions Reported by Ronald C. Renaud Jr.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored